Co4B Co4B fusion protein with increased immune response induction ability and vaccine composition for preventing or treating Middle East respiratory syndrome comprising the same as effective component
The present invention relates to a vaccine composition for preventing or treating Middle East Respiratory Syndrome containing the Co4B fusion protein having an increased immune response inducing ability consisting of the amino acid sequence of SEQ ID NO: 2 and the fusion protein as an active ingredient.본 발명은 서열번호 2의 아미노산 서열로 이루어진 면역반응 유도능이 증가된 Co4B 융합 단백질 및 상기 융합 단백질을 유효성분으로 함유하는 중동호흡기증후군의 예방 또는 치료용 백신 조성물에 관한 것이다.